Product
mRNA NA vaccine
1 clinical trial
2 indications
Indication
Influenza ImmunizationIndication
Healthy Control ParticipantsClinical trial
Phase I, Randomized, Modified Double-blind, Parallel-group, Active-controlled, Multi-arm, Dose-escalation Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and OlderStatus: Completed, Estimated PCD: 2024-01-03